Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 585

1.

DNA recovery from archived RDTs for genetic characterization of Plasmodium falciparum in a routine setting in Lambaréné, Gabon.

Nguyen TT, Nzigou Mombo B, Lalremruata A, Koehne E, Zoleko Manego R, Dimessa Mbadinga LB, Adegnika AA, Agnandji ST, Lell B, Kremsner PG, Velavan TP, Ramharter M, Mordmüller B, Mombo-Ngoma G.

Malar J. 2019 Oct 2;18(1):336. doi: 10.1186/s12936-019-2972-y.

2.

Transcriptome profiling reveals functional variation in Plasmodium falciparum parasites from controlled human malaria infection studies.

Hoo R, Bruske E, Dimonte S, Zhu L, Mordmüller B, Sim BKL, Kremsner PG, Hoffman SL, Bozdech Z, Frank M, Preiser PR.

EBioMedicine. 2019 Sep 11. pii: S2352-3964(19)30599-7. doi: 10.1016/j.ebiom.2019.09.001. [Epub ahead of print]

3.

Controlled human malaria infection with Plasmodium falciparum demonstrates impact of naturally acquired immunity on virulence gene expression.

Bachmann A, Bruske E, Krumkamp R, Turner L, Wichers JS, Petter M, Held J, Duffy MF, Sim BKL, Hoffman SL, Kremsner PG, Lell B, Lavstsen T, Frank M, Mordmüller B, Tannich E.

PLoS Pathog. 2019 Jul 11;15(7):e1007906. doi: 10.1371/journal.ppat.1007906. eCollection 2019 Jul.

4.

An alternative dogma on reduced artemisinin susceptibility: A new shadow from east to west.

Velavan TP, Nderu D, Agbenyega T, Ntoumi F, Kremsner PG.

Proc Natl Acad Sci U S A. 2019 Jun 25;116(26):12611-12612. doi: 10.1073/pnas.1907142116. No abstract available.

5.

A long-term follow-up study on otoacoustic emissions testing in paediatric patients with severe malaria in Gabon.

Reiterer E, Reider S, Lackner P, Fischer N, Dejaco D, Riechelmann H, Zorowka P, Kremsner PG, Adegnika AA, Schmutzhard E, Schmutzhard J.

Malar J. 2019 Jun 24;18(1):212. doi: 10.1186/s12936-019-2840-9.

6.

Ivermectin Impairs the Development of Sexual and Asexual Stages of Plasmodium falciparum In Vitro.

de Carvalho LP, Sandri TL, José Tenório de Melo E, Fendel R, Kremsner PG, Mordmüller B, Held J.

Antimicrob Agents Chemother. 2019 Jul 25;63(8). pii: e00085-19. doi: 10.1128/AAC.00085-19. Print 2019 Aug.

PMID:
31109978
7.

Implementation of multidrug-resistant tuberculosis (MDR-TB) treatment in Gabon: lessons learnt from the field.

Ateba-Ngoa U, Edoa JR, Adegbite BR, Rossatanga EG, Madiou D, Mfoumbi A, Mevyann C, Achimi Agbo P, Mahoumbou J, Gould S, Lell B, Adegnika AA, Köhler C, Kremsner PG, Massinga-Loembe M, Alabi A, Grobusch MP.

Infection. 2019 Oct;47(5):811-816. doi: 10.1007/s15010-019-01314-5. Epub 2019 May 9.

PMID:
31073710
8.

Prospective Clinical and Molecular Evaluation of Potential Plasmodium ovale curtisi and wallikeri Relapses in a High-transmission Setting.

Groger M, Veletzky L, Lalremruata A, Cattaneo C, Mischlinger J, Manego Zoleko R, Kim J, Klicpera A, Meyer EL, Blessborn D, Winterberg M, Adegnika AA, Agnandji ST, Kremsner PG, Mordmüller B, Mombo-Ngoma G, Fuehrer HP, Ramharter M.

Clin Infect Dis. 2019 Apr 19. pii: ciz131. doi: 10.1093/cid/ciz131. [Epub ahead of print]

PMID:
31066448
9.

NTCP S267F variant associates with decreased susceptibility to HBV and HDV infection and decelerated progression of related liver diseases.

Binh MT, Hoan NX, Van Tong H, Sy BT, Trung NT, Bock CT, Toan NL, Song LH, Bang MH, Meyer CG, Kremsner PG, Velavan TP.

Int J Infect Dis. 2019 Mar;80:147-152. doi: 10.1016/j.ijid.2019.01.038. Epub 2019 Jan 24.

10.

The blood transcriptome of childhood malaria.

Boldt ABW, van Tong H, Grobusch MP, Kalmbach Y, Dzeing Ella A, Kombila M, Meyer CG, Kun JFJ, Kremsner PG, Velavan TP.

EBioMedicine. 2019 Feb;40:614-625. doi: 10.1016/j.ebiom.2018.12.055. Epub 2019 Jan 10.

11.

First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated Malaria.

Mordmüller B, Sulyok M, Egger-Adam D, Resende M, de Jongh WA, Jensen MH, Smedegaard HH, Ditlev SB, Soegaard M, Poulsen L, Dyring C, Calle CL, Knoblich A, Ibáñez J, Esen M, Deloron P, Ndam N, Issifou S, Houard S, Howard RF, Reed SG, Leroy O, Luty AJF, Theander TG, Kremsner PG, Salanti A, Nielsen MA.

Clin Infect Dis. 2019 Oct 15;69(9):1509-1516. doi: 10.1093/cid/ciy1140.

12.

Controlled Human Malaria Infection of Healthy Adults With Lifelong Malaria Exposure to Assess Safety, Immunogenicity, and Efficacy of the Asexual Blood Stage Malaria Vaccine Candidate GMZ2.

Dejon-Agobe JC, Ateba-Ngoa U, Lalremruata A, Homoet A, Engelhorn J, Nouatin OP, Edoa JR, Fernandes JF, Esen M, Mouwenda YD, Betouke Ongwe EM, Massinga-Loembe M, Hoffman SL, Sim BKL, Theisen M, Kremsner PG, Adegnika AA, Lell B, Mordmüller B.

Clin Infect Dis. 2019 Sep 27;69(8):1377-1384. doi: 10.1093/cid/ciy1087.

PMID:
30561539
13.

Population Pharmacokinetics of Mefloquine Intermittent Preventive Treatment for Malaria in Pregnancy in Gabon.

Ramharter M, Schwab M, Mombo-Ngoma G, Zoleko Manego R, Akerey-Diop D, Basra A, Mackanga JR, Würbel H, Wojtyniak JG, Gonzalez R, Hofmann U, Geditz M, Matsiegui PB, Kremsner PG, Menendez C, Kerb R, Lehr T.

Antimicrob Agents Chemother. 2019 Jan 29;63(2). pii: e01113-18. doi: 10.1128/AAC.01113-18. Print 2019 Feb.

14.

Correlating efficacy and immunogenicity in malaria vaccine trials.

McCall MBB, Kremsner PG, Mordmüller B.

Semin Immunol. 2018 Oct;39:52-64. doi: 10.1016/j.smim.2018.08.002. Epub 2018 Sep 12. Review.

PMID:
30219621
15.

Complement 5a Receptor Polymorphisms Are Associated With Panton-Valentine Leukocidin-positive Staphylococcus aureus Colonization in African Pygmies.

Schaumburg F, Witten A, Flamen A, Stoll M, Alabi AS, Kremsner PG, Löffler B, Zipfel PF, Velavan TP, Peters G.

Clin Infect Dis. 2019 Feb 15;68(5):854-856. doi: 10.1093/cid/ciy666.

PMID:
30192927
16.

Concordance of three alternative gestational age assessments for pregnant women from four African countries: A secondary analysis of the MIPPAD trial.

Rada S, Gamper J, González R, Mombo-Ngoma G, Ouédraogo S, Kakolwa MA, Zoleko-Manego R, Sevene E, Kabanywanyi AM, Accrombessi M, Briand V, Cot M, Vala A, Kremsner PG, Abdulla S, Massougbodgi A, Nhacolo A, Aponte JJ, Macete E, Menéndez C, Ramharter M.

PLoS One. 2018 Aug 6;13(8):e0199243. doi: 10.1371/journal.pone.0199243. eCollection 2018.

17.

Schistosoma haematobium effects on Plasmodium falciparum infection modified by soil-transmitted helminths in school-age children living in rural areas of Gabon.

Dejon-Agobé JC, Zinsou JF, Honkpehedji YJ, Ateba-Ngoa U, Edoa JR, Adegbite BR, Mombo-Ngoma G, Agnandji ST, Ramharter M, Kremsner PG, Lell B, Grobusch MP, Adegnika AA.

PLoS Negl Trop Dis. 2018 Aug 6;12(8):e0006663. doi: 10.1371/journal.pntd.0006663. eCollection 2018 Aug.

18.

Progressive ulcer on the tongue due to local histoplasmosis.

Bissinger AL, Biegner T, Frank M, Kremsner PG.

Infection. 2018 Dec;46(6):903-904. doi: 10.1007/s15010-018-1187-4. Epub 2018 Aug 3. No abstract available.

PMID:
30074229
19.

Validity and reliability of methods to microscopically detect and quantify malaria parasitaemia.

Mischlinger J, Pitzinger P, Veletzky L, Groger M, Zoleko-Manego R, Adegnika AA, Agnandji ST, Lell B, Kremsner PG, Mombo-Ngoma G, Mordmüller B, Ramharter M.

Trop Med Int Health. 2018 Sep;23(9):980-991. doi: 10.1111/tmi.13124. Epub 2018 Jul 17.

20.

Corrigendum to "Epidemiology and population structure of Staphylococcus aureus in various population groups from a rural and semi urban area in Gabon, Central Africa" [Acta Trop. 124 (2012) 42-47].

Ngoa UA, Schaumburg F, Adegnika AA, Kösters K, Möller T, Gaus E, Fernandes JF, Alabi A, Issifou S, Becker K, Grobusch MP, Kremsner PG, Lell B.

Acta Trop. 2018 Sep;185:422. doi: 10.1016/j.actatropica.2018.05.012. Epub 2018 Jun 7. No abstract available.

PMID:
29887385
21.

Antihomotypic affinity maturation improves human B cell responses against a repetitive epitope.

Imkeller K, Scally SW, Bosch A, Martí GP, Costa G, Triller G, Murugan R, Renna V, Jumaa H, Kremsner PG, Sim BKL, Hoffman SL, Mordmüller B, Levashina EA, Julien JP, Wardemann H.

Science. 2018 Jun 22;360(6395):1358-1362. doi: 10.1126/science.aar5304. Epub 2018 Jun 7.

22.

Use of Capillary Blood Samples Leads to Higher Parasitemia Estimates and Higher Diagnostic Sensitivity of Microscopic and Molecular Diagnostics of Malaria Than Venous Blood Samples.

Mischlinger J, Pitzinger P, Veletzky L, Groger M, Zoleko-Manego R, Adegnika AA, Agnandji ST, Lell B, Kremsner PG, Tannich E, Mombo-Ngoma G, Mordmüller B, Ramharter M.

J Infect Dis. 2018 Sep 8;218(8):1296-1305. doi: 10.1093/infdis/jiy319.

PMID:
29800345
23.

HDV infection rates in northern Vietnam.

Binh MT, Hoan NX, Van Tong H, Giang DP, Sy BT, Toan NL, Song LH, Bang MH, Wedemeyer H, Meyer CG, Kremsner PG, Bock CT, Velavan TP.

Sci Rep. 2018 May 23;8(1):8047. doi: 10.1038/s41598-018-26446-w.

24.

Clonal selection drives protective memory B cell responses in controlled human malaria infection.

Murugan R, Buchauer L, Triller G, Kreschel C, Costa G, Pidelaserra Martí G, Imkeller K, Busse CE, Chakravarty S, Sim BKL, Hoffman SL, Levashina EA, Kremsner PG, Mordmüller B, Höfer T, Wardemann H.

Sci Immunol. 2018 Feb 16;3(20). pii: eaap8029. doi: 10.1126/sciimmunol.aap8029.

PMID:
29453292
25.

Human complement receptor type 1 (CR1) protein levels and genetic variants in chronic Chagas Disease.

Sandri TL, Lidani KCF, Andrade FA, Meyer CG, Kremsner PG, de Messias-Reason IJ, Velavan TP.

Sci Rep. 2018 Jan 11;8(1):526. doi: 10.1038/s41598-017-18937-z.

26.

Prospective Clinical Trial Assessing Species-Specific Efficacy of Artemether-Lumefantrine for the Treatment of Plasmodium malariae, Plasmodium ovale, and Mixed Plasmodium Malaria in Gabon.

Groger M, Veletzky L, Lalremruata A, Cattaneo C, Mischlinger J, Zoleko-Manego R, Endamne L, Klicpera A, Kim J, Nguyen T, Flohr L, Remppis J, Matsiegui PB, Adegnika AA, Agnandji ST, Kremsner PG, Mordmüller B, Mombo-Ngoma G, Ramharter M.

Antimicrob Agents Chemother. 2018 Feb 23;62(3). pii: e01758-17. doi: 10.1128/AAC.01758-17. Print 2018 Mar.

27.

Efficacy and Safety of Fosmidomycin-Piperaquine as Nonartemisinin-Based Combination Therapy for Uncomplicated Falciparum Malaria: A Single-Arm, Age De-escalation Proof-of-Concept Study in Gabon.

Mombo-Ngoma G, Remppis J, Sievers M, Zoleko Manego R, Endamne L, Kabwende L, Veletzky L, Nguyen TT, Groger M, Lötsch F, Mischlinger J, Flohr L, Kim J, Cattaneo C, Hutchinson D, Duparc S, Moehrle J, Velavan TP, Lell B, Ramharter M, Adegnika AA, Mordmüller B, Kremsner PG.

Clin Infect Dis. 2018 Jun 1;66(12):1823-1830. doi: 10.1093/cid/cix1122.

28.

Impact of Sickle Cell Trait and Naturally Acquired Immunity on Uncomplicated Malaria after Controlled Human Malaria Infection in Adults in Gabon.

Lell B, Mordmüller B, Dejon Agobe JC, Honkpehedji J, Zinsou J, Mengue JB, Loembe MM, Adegnika AA, Held J, Lalremruata A, Nguyen TT, Esen M, Kc N, Ruben AJ, Chakravarty S, Lee Sim BK, Billingsley PF, James ER, Richie TL, Hoffman SL, Kremsner PG.

Am J Trop Med Hyg. 2018 Feb;98(2):508-515. doi: 10.4269/ajtmh.17-0343. Epub 2017 Dec 14.

29.

Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis.

Staines HM, Burrow R, Teo BH, Chis Ster I, Kremsner PG, Krishna S.

J Antimicrob Chemother. 2018 Mar 1;73(3):581-595. doi: 10.1093/jac/dkx431.

30.

Rare PfCSP C-terminal antibodies induced by live sporozoite vaccination are ineffective against malaria infection.

Scally SW, Murugan R, Bosch A, Triller G, Costa G, Mordmüller B, Kremsner PG, Sim BKL, Hoffman SL, Levashina EA, Wardemann H, Julien JP.

J Exp Med. 2018 Jan 2;215(1):63-75. doi: 10.1084/jem.20170869. Epub 2017 Nov 22.

31.

Controlled human infections: A report from the controlled human infection models workshop, Leiden University Medical Centre 4-6 May 2016.

Roestenberg M, Mo A, Kremsner PG, Yazdanbakhsh M.

Vaccine. 2017 Dec 18;35(51):7070-7076. doi: 10.1016/j.vaccine.2017.10.092. Epub 2017 Nov 20.

32.

The frontline of controlled human malaria infections: A report from the controlled human infection models Workshop in Leiden University Medical Centre 5 May 2016.

Roestenberg M, Mordmüller B, Ockenhouse C, Mo A, Yazdanbakhsh M, Kremsner PG.

Vaccine. 2017 Dec 18;35(51):7065-7069. doi: 10.1016/j.vaccine.2017.10.093. Epub 2017 Nov 17.

33.

A randomised, double-blind clinical phase II trial of the efficacy, safety, tolerability and pharmacokinetics of a single dose combination treatment with artefenomel and piperaquine in adults and children with uncomplicated Plasmodium falciparum malaria.

Macintyre F, Adoke Y, Tiono AB, Duong TT, Mombo-Ngoma G, Bouyou-Akotet M, Tinto H, Bassat Q, Issifou S, Adamy M, Demarest H, Duparc S, Leroy D, Laurijssens BE, Biguenet S, Kibuuka A, Tshefu AK, Smith M, Foster C, Leipoldt I, Kremsner PG, Phuc BQ, Ouedraogo A, Ramharter M; OZ-Piperaquine Study Group.

BMC Med. 2017 Oct 9;15(1):181. doi: 10.1186/s12916-017-0940-3.

34.

Safety and immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in adults and children in Lambaréné, Gabon: A phase I randomised trial.

Agnandji ST, Fernandes JF, Bache EB, Obiang Mba RM, Brosnahan JS, Kabwende L, Pitzinger P, Staarink P, Massinga-Loembe M, Krähling V, Biedenkopf N, Fehling SK, Strecker T, Clark DJ, Staines HM, Hooper JW, Silvera P, Moorthy V, Kieny MP, Adegnika AA, Grobusch MP, Becker S, Ramharter M, Mordmüller B, Lell B; VEBCON Consortium, Krishna S, Kremsner PG.

PLoS Med. 2017 Oct 6;14(10):e1002402. doi: 10.1371/journal.pmed.1002402. eCollection 2017 Oct.

35.

Species and genotype diversity of Plasmodium in malaria patients from Gabon analysed by next generation sequencing.

Lalremruata A, Jeyaraj S, Engleitner T, Joanny F, Lang A, Bélard S, Mombo-Ngoma G, Ramharter M, Kremsner PG, Mordmüller B, Held J.

Malar J. 2017 Oct 3;16(1):398. doi: 10.1186/s12936-017-2044-0.

36.

Life-span of in vitro differentiated Plasmodium falciparum gametocytes.

Gebru T, Lalremruata A, Kremsner PG, Mordmüller B, Held J.

Malar J. 2017 Aug 11;16(1):330. doi: 10.1186/s12936-017-1986-6.

37.

Phase 2a, Open-Label, 4-Escalating-Dose, Randomized Multicenter Study Evaluating the Safety and Activity of Ferroquine (SSR97193) Plus Artesunate, versus Amodiaquine Plus Artesunate, in African Adult Men with Uncomplicated Plasmodium falciparum Malaria.

Supan C, Mombo-Ngoma G, Kombila M, Ospina Salazar CL, Held J, Lell B, Cantalloube C, Djeriou E, Ogutu B, Waitumbi J, Otsula N, Apollo D, Polhemus ME, Kremsner PG, Walsh DS.

Am J Trop Med Hyg. 2017 Aug;97(2):514-525. doi: 10.4269/ajtmh.16-0731. Epub 2017 Jul 19.

38.

Resisting and tolerating P. falciparum in pregnancy under different malaria transmission intensities.

Ndam NT, Mbuba E, González R, Cisteró P, Kariuki S, Sevene E, Rupérez M, Fonseca AM, Vala A, Maculuve S, Jiménez A, Quintó L, Ouma P, Ramharter M, Aponte JJ, Nhacolo A, Massougbodji A, Briand V, Kremsner PG, Mombo-Ngoma G, Desai M, Macete E, Cot M, Menéndez C, Mayor A.

BMC Med. 2017 Jul 17;15(1):130. doi: 10.1186/s12916-017-0893-6.

39.

Pyruvate Kinase and Fcγ Receptor Gene Copy Numbers Associated With Malaria Phenotypes.

Faik I, van Tong H, Lell B, Meyer CG, Kremsner PG, Velavan TP.

J Infect Dis. 2017 Jul 15;216(2):276-282. doi: 10.1093/infdis/jix284.

PMID:
28605553
40.

Molecular markers of anti-malarial drug resistance in Central, West and East African children with severe malaria.

Nguetse CN, Adegnika AA, Agbenyega T, Ogutu BR, Krishna S, Kremsner PG, Velavan TP.

Malar J. 2017 May 23;16(1):217. doi: 10.1186/s12936-017-1868-y.

41.

Geographical distribution of complement receptor type 1 variants and their associated disease risk.

Lucas Sandri T, Adukpo S, Giang DP, Nguetse CN, Antunes Andrade F, Tong HV, Toan NL, Song LH, Elumalai P, Thangaraj K, Valluri VL, Ntoumi F, Meyer CG, Jose de Messias Reason I, Kremsner PG, Velavan TP.

PLoS One. 2017 May 17;12(5):e0175973. doi: 10.1371/journal.pone.0175973. eCollection 2017.

42.

Serum Lipids and Lipoproteins During Uncomplicated Malaria: A Cohort Study in Lambaréné, Gabon.

Visser BJ, de Vries SG, Vingerling R, Gritter M, Kroon D, Aguilar LC, Kraan RBJ, Wieten RW, Danion F, Sjouke B, Adegnika AA, Agnandji ST, Kremsner PG, Hänscheid T, Mens PF, van Vugt M, Grobusch MP.

Am J Trop Med Hyg. 2017 May;96(5):1205-1214. doi: 10.4269/ajtmh.16-0721.

43.

Safety and efficacy of the choline analogue SAR97276 for malaria treatment: results of two phase 2, open-label, multicenter trials in African patients.

Held J, Supan C, Salazar CLO, Tinto H, Bonkian LN, Nahum A, Sié A, Abdulla S, Cantalloube C, Djeriou E, Bouyou-Akotet M, Ogutu B, Mordmüller B, Kreidenweiss A, Siribie M, Sirima SB, Kremsner PG.

Malar J. 2017 May 4;16(1):188. doi: 10.1186/s12936-017-1832-x.

44.

Recognition of Plasmodium falciparum mature gametocyte-infected erythrocytes by antibodies of semi-immune adults and malaria-exposed children from Gabon.

Gebru T, Ajua A, Theisen M, Esen M, Ngoa UA, Issifou S, Adegnika AA, Kremsner PG, Mordmüller B, Held J.

Malar J. 2017 Apr 26;16(1):176. doi: 10.1186/s12936-017-1827-7.

45.

A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa.

Huttner A, Combescure C, Grillet S, Haks MC, Quinten E, Modoux C, Agnandji ST, Brosnahan J, Dayer JA, Harandi AM, Kaiser L, Medaglini D, Monath T; VEBCON and VSV-EBOVAC Consortia, Roux-Lombard P, Kremsner PG, Ottenhoff TH, Siegrist CA.

Sci Transl Med. 2017 Apr 12;9(385). pii: eaaj1701. doi: 10.1126/scitranslmed.aaj1701. Erratum in: Sci Transl Med. 2019 Aug 21;11(506):.

46.

DSM265 for Plasmodium falciparum chemoprophylaxis: a randomised, double blinded, phase 1 trial with controlled human malaria infection.

Sulyok M, Rückle T, Roth A, Mürbeth RE, Chalon S, Kerr N, Samec SS, Gobeau N, Calle CL, Ibáñez J, Sulyok Z, Held J, Gebru T, Granados P, Brückner S, Nguetse C, Mengue J, Lalremruata A, Sim BKL, Hoffman SL, Möhrle JJ, Kremsner PG, Mordmüller B.

Lancet Infect Dis. 2017 Jun;17(6):636-644. doi: 10.1016/S1473-3099(17)30139-1. Epub 2017 Mar 28. Erratum in: Lancet Infect Dis. 2017 Jun;17(6):576.

47.

Low incidence of the immune reconstitution inflammatory syndrome among HIV-infected patients starting antiretroviral therapy in Gabon: a prospective cohort study.

Janssen S, Osbak K, Holman R, Hermans S, Moekotte A, Knap M, Rossatanga E, Massinga-Loembe M, Alabi A, Adegnika A, Meenken C, van Vugt M, Kremsner PG, Meintjes G, van der Poll T, Grobusch MP.

Infection. 2017 Oct;45(5):669-676. doi: 10.1007/s15010-017-1000-9. Epub 2017 Mar 27.

48.

Community-Associated Staphylococcus aureus from Sub-Saharan Africa and Germany: A Cross-Sectional Geographic Correlation Study.

Ruffing U, Alabi A, Kazimoto T, Vubil DC, Akulenko R, Abdulla S, Alonso P, Bischoff M, Germann A, Grobusch MP, Helms V, Hoffmann J, Kern WV, Kremsner PG, Mandomando I, Mellmann A, Peters G, Schaumburg F, Schubert S, Strauß L, Tanner M, Briesen HV, Wende L, Müller LV, Herrmann M.

Sci Rep. 2017 Mar 13;7(1):154. doi: 10.1038/s41598-017-00214-8.

49.

Sterile protection against human malaria by chemoattenuated PfSPZ vaccine.

Mordmüller B, Surat G, Lagler H, Chakravarty S, Ishizuka AS, Lalremruata A, Gmeiner M, Campo JJ, Esen M, Ruben AJ, Held J, Calle CL, Mengue JB, Gebru T, Ibáñez J, Sulyok M, James ER, Billingsley PF, Natasha KC, Manoj A, Murshedkar T, Gunasekera A, Eappen AG, Li T, Stafford RE, Li M, Felgner PL, Seder RA, Richie TL, Sim BK, Hoffman SL, Kremsner PG.

Nature. 2017 Feb 23;542(7642):445-449. doi: 10.1038/nature21060. Epub 2017 Feb 15.

PMID:
28199305
50.

SOCS3 genetic variants and promoter hypermethylation in patients with chronic hepatitis B.

Hoan NX, Van Tong H, Giang DP, Cuong BK, Toan NL, Wedemeyer H, Bock CT, Kremsner PG, Song LH, Velavan TP.

Oncotarget. 2017 Mar 7;8(10):17127-17139. doi: 10.18632/oncotarget.15083.

Supplemental Content

Loading ...
Support Center